{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:27:58Z","timestamp":1790692078559,"version":"4.1.0"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,10,9]],"date-time":"2018-10-09T00:00:00Z","timestamp":1539043200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2018.02310","type":"journal-article","created":{"date-parts":[[2018,10,9]],"date-time":"2018-10-09T05:30:28Z","timestamp":1539063028000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":21,"title":["Intrarenal Complement System Transcripts in Chronic Antibody-Mediated Rejection and Recurrent IgA Nephropathy in Kidney Transplantation"],"prefix":"10.3389","volume":"9","author":[{"given":"Marek","family":"Cernoch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Hruba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marek","family":"Kollar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Mrazova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Stranavova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alena","family":"Lodererova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Honsova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ondrej","family":"Viklicky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,10,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.1111\/j.1600-6143.2009.02799.x","article-title":"Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure","volume":"9","author":"Einecke","year":"2009","journal-title":"Am J Transplant."},{"key":"B2","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1097\/TP.0b013e3181e065de","article-title":"Evidence for antibody-mediated injury as a major determinant of late kidney allograft failure","volume":"90","author":"Gaston","year":"2010","journal-title":"Transplantation"},{"key":"B3","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1097\/MOT.0000000000000072","article-title":"An updated Banff schema for diagnosis of antibody-mediated rejection in renal allografts","volume":"19","author":"Haas","year":"2014","journal-title":"Curr Opin Organ Transplant."},{"key":"B4","doi-asserted-by":"publisher","first-page":"e0162278","DOI":"10.1371\/journal.pone.0162278","article-title":"The spectrum of renal allograft failure","volume":"11","author":"Chand","year":"2016","journal-title":"PLoS ONE"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1093\/ndt\/gfs472","article-title":"The long-term outcome of renal transplantation of IgA nephropathy and the impact of recurrence on graft survival","volume":"28","author":"Moroni","year":"2013","journal-title":"Nephrol Dial Transplant."},{"key":"B6","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s40620-014-0090-z","article-title":"Nationwide biopsy survey of renal diseases in the Czech Republic during the years 1994-2011","volume":"28","author":"Maixnerova","year":"2015","journal-title":"J Nephrol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1038\/ki.1987.72","article-title":"Complement membrane attack (MAC) in idiopathic IgA-glomerulonephritis","volume":"31","author":"Rauterberg","year":"1987","journal-title":"Kidney Int."},{"key":"B8","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1097\/TP.0b013e3181b0517d","article-title":"Expression of the decay-accelerating factor (CD55) in renal transplants\u2013a possible prediction marker of allograft survival","volume":"88","author":"Brodsky","year":"2009","journal-title":"Transplantation"},{"key":"B9","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/1471-2369-12-64","article-title":"Excretion of complement proteins and its activation marker C5b-9 in IgA nephropathy in relation to renal function","volume":"12","author":"Onda","year":"2011","journal-title":"BMC Nephrol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/j.transproceed.2015.12.126","article-title":"A promoter polymorphism in the CD46 complement regulatory protein gene is associated with acute renal allograft rejection","volume":"48","author":"Park","year":"2016","journal-title":"Transplant Proc."},{"key":"B11","doi-asserted-by":"publisher","first-page":"3187","DOI":"10.1681\/ASN.2015111210","article-title":"Fine mapping implicates a deletion of CFHR1 and CFHR3 in protection from IgA nephropathy in Han Chinese","volume":"27","author":"Xie","year":"2016","journal-title":"J Am Soc Nephrol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1111\/j.1600-6143.2011.03757.x","article-title":"Terminal complement inhibition decreases antibody-mediated rejection in sensitized renal transplant recipients","volume":"11","author":"Stegall","year":"2011","journal-title":"Am J Transplant."},{"key":"B13","doi-asserted-by":"publisher","first-page":"9874261","DOI":"10.1155\/2016\/9874261","article-title":"Eculizumab for the treatment of severe antibody-mediated rejection: a case report and review of the literature","volume":"2016","author":"Tran","year":"2016","journal-title":"Case Rep Transplant."},{"key":"B14","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1097\/TP.0000000000000592","article-title":"A phase I\/II placebo-controlled trial of C1-inhibitor for prevention of antibody-mediated rejection in HLA sensitized patients","volume":"99","author":"Vo","year":"2015","journal-title":"Transplantation"},{"key":"B15","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.1111\/ajt.14256","article-title":"Effect of the anti-C1s humanized antibody TNT009 and its parental mouse variant TNT003 on HLA antibody-induced complement activation-a preclinical in vitro study","volume":"17","author":"Wahrmann","year":"2017","journal-title":"Am J Transplant."},{"key":"B16","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1111\/j.1600-6143.2008.02159.x","article-title":"Banff 07 classification of renal allograft pathology: updates and future directions","volume":"8","author":"Solez","year":"2008","journal-title":"Am J Transplant"},{"key":"B17","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1111\/j.1600-6143.2009.02987.x","article-title":"Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups","volume":"10","author":"Sis","year":"2010","journal-title":"Am J Transplant."},{"key":"B18","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1111\/j.1600-6143.2011.03926.x","article-title":"Banff 2011 Meeting report: new concepts in antibody-mediated rejection","volume":"12","author":"Mengel","year":"2012","journal-title":"Am J Transplant"},{"key":"B19","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1111\/ajt.12590","article-title":"Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions","volume":"14","author":"Haas","year":"2014","journal-title":"Am J Transplant."},{"key":"B20","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1097\/MOT.0000000000000037","article-title":"Mechanisms of rejection: role of complement","volume":"19","author":"Farrar","year":"2014","journal-title":"Curr Opin Organ Transplant."},{"key":"B21","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1097\/MOT.0000000000000216","article-title":"Effects of complement activation on allograft injury","volume":"20","author":"Sheen","year":"2015","journal-title":"Curr Opin Organ Transplant."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40620-015-0245-6","article-title":"Role of complement in IgA nephropathy","volume":"29","author":"Daha","year":"2016","journal-title":"J Nephrol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1159\/000189529","article-title":"Membrane attack complex and membrane cofactor protein are related to tubulointerstitial inflammation in various human glomerulopathies","volume":"75","author":"Mosolits","year":"1997","journal-title":"Nephron"},{"key":"B24","doi-asserted-by":"publisher","first-page":"31","DOI":"10.5527\/wjn.v4.i1.31","article-title":"Complement activation in progressive renal disease","volume":"4","author":"Fearn","year":"2015","journal-title":"World J Nephrol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"66","DOI":"10.3389\/fmed.2017.00066","article-title":"Complement in kidney transplantation","volume":"4","author":"Cernoch","year":"2017","journal-title":"Front Med."},{"key":"B26","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/nep.12195","article-title":"Atypical HUS associated with severe, unexpected antibody-mediated rejection post kidney transplant","volume":"19","author":"Stevenson","year":"2014","journal-title":"Nephrology"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfy064","article-title":"Defective gene expression of the membrane complement inhibitor CD46 in patients with progressive immunoglobulin A nephropathy","author":"Coppo","year":"2018","journal-title":"Nephrol Dial Transplant."},{"key":"B28","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/0014-5793(94)00463-3","article-title":"Activation of human neutrophils by C3a and C5A. Comparison of the effects on shape changes, chemotaxis, secretion, and respiratory burst","volume":"346","author":"Ehrengruber","year":"1994","journal-title":"FEBS Lett."},{"key":"B29","doi-asserted-by":"crossref","first-page":"453","DOI":"10.4049\/jimmunol.162.1.453","article-title":"Regulation of IL-6 synthesis in human peripheral blood mononuclear cells by C3a and C3a(desArg)","volume":"162","author":"Fischer","year":"1999","journal-title":"J Immunol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.1016\/j.molimm.2009.04.027","article-title":"The role of the anaphylatoxins in health and disease","volume":"46","author":"Klos","year":"2009","journal-title":"Mol Immunol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s10157-017-1469-7","article-title":"Allo-specific immune response profiles indicative of acute rejection in kidney allografts using an in vitro lymphocyte culture-based model","volume":"22","author":"Mahakur","year":"2018","journal-title":"Clin Exp Nephrol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1186\/s12882-017-0658-7","article-title":"Increased C4 and decreased C3 levels are associated with a poor prognosis in patients with immunoglobulin A nephropathy: a retrospective study","volume":"18","author":"Pan","year":"2017","journal-title":"BMC Nephrol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1056\/NEJMoa1302506","article-title":"Complement-binding anti-HLA antibodies and kidney-allograft survival","volume":"369","author":"Loupy","year":"2013","journal-title":"N Engl J Med."},{"key":"B34","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/ki.2010.75","article-title":"Recombinant human C1-inhibitor prevents acute antibody-mediated rejection in alloimmunized baboons","volume":"78","author":"Tillou","year":"2010","journal-title":"Kidney Int."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1111\/ajt.13663","article-title":"C1 inhibitor in acute antibody-mediated rejection nonresponsive to conventional therapy in kidney transplant recipients: a pilot study","volume":"16","author":"Viglietti","year":"2016","journal-title":"Am J Transplant."},{"key":"B36","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1113\/jphysiol.2001.013381","article-title":"CD59 blocks not only the insertion of C9 into MAC but inhibits ion channel formation by homologous C5b-8 as well as C5b-9","volume":"539","author":"Farkas","year":"2002","journal-title":"J Physiol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1097\/TP.0b013e3181a19afc","article-title":"Upregulation of CD59: potential mechanism of accommodation in a large animal model","volume":"87","author":"Griesemer","year":"2009","journal-title":"Transplantation"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.02310\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T20:02:02Z","timestamp":1693944122000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.02310\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,9]]},"references-count":37,"alternative-id":["10.3389\/fimmu.2018.02310"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2018.02310","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,9]]},"article-number":"2310"}}